Home › Funds › McLaughlin Asset Management, Inc. › ABBV

McLaughlin Asset Management, Inc. position in ABBV

ABBVIE INCORPORATED · Health Care

McLaughlin Asset Management, Inc. reported holding 3,893 shares of ABBV (ABBVIE INCORPORATED) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.80% of its reported portfolio and ranking #41 among its reported holdings. McLaughlin Asset Management, Inc. has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.89K sh
Reported value held$1.02M
Portfolio Weight0.80%
First reportedQ4 2025
Last changeAdd
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How McLaughlin Asset Management, Inc.'s ABBV position evolved

McLaughlin Asset Management, Inc. first disclosed a stake in ABBV in Q4 2025 at 4,063 shares (US$928K). The position peaked in Q3 2026 at 3,893 shares, worth US$1.0M. Across 4 filings, McLaughlin Asset Management, Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,893 shares valued at US$1.0M — an increase of 188 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.06K $928.47K New
Q1 2026 3.96K $860.93K Reduce
Q2 2026 3.71K $932.45K Reduce
Q3 2026 3.89K $1.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INCORPORATED) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has McLaughlin Asset Management, Inc. held ABBV?

McLaughlin Asset Management, Inc. has disclosed ABBV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is McLaughlin Asset Management, Inc.'s current position in ABBV?

As of Q3 2026, McLaughlin Asset Management, Inc. holds 3.89K shares of ABBV (ABBVIE INCORPORATED), valued at $1.02M, representing 0.80% of its reported portfolio and ranking #41.

Has McLaughlin Asset Management, Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), McLaughlin Asset Management, Inc. increased its position in ABBV. The position peaked in Q3 2026 at 3.89K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.